Back to Results
First PageMeta Content
Biochemical recurrence / Androgen deprivation therapy / MCRPC / Metastasis / Prostate / Radiation therapy / Management of prostate cancer / William K. Oh / Medicine / Oncology / Prostate cancer


Issues Concerning Development of Products for Treatment of Non-Metastatic CastrationResistant Prostate Cancer (NM-CRPC) FDA Presentation ODAC Meeting
Add to Reading List

Open Document

File Size: 186,15 KB

Share Result on Facebook

Company

Non-Metastatic CastrationResistant Prostate Cancer / Metastatic Castration Resistant Metastatic Castration Resistant / /

Country

United States / /

Facility

Lupron Depot / /

IndustryTerm

Treatment of Non-Metastatic CastrationResistant Prostate Cancer / treatment of Advanced Prostate Cancer / /

MedicalCondition

metastatic disease / Recurrent Prostate Cancer / localized / asymptomatic disease / Non-metastatic prostate cancer / Advanced Prostate Cancer / common cancer / Cancer / metastasis / Prostate Cancer / metastases / Advanced Carcinoma / /

MedicalTreatment

radiation therapy / prostatectomy / /

Organization

FDA / /

Person

Y. Max Ning / Paul G. Kluetz / John Johnson / /

Product

Lupron Depot / Zoladex / /

Technology

radiation / /

SocialTag